| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 64 |
| 1 | BROLUCIZUMAB | 47 |
| 2 | DEXAMETHASONE | 41 |
| 3 | BEVACIZUMAB | 40 |
| 4 | AFLIBERCEPT | 37 |
| 5 | PREDNISONE | 36 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 31 |
| 7 | ASPIRIN | 30 |
| 8 | ASPIRIN 325 MG | 30 |
| 9 | ASPIRIN 81 MG | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VERTEPORFIN FOR INJECTION | 13 | 0.0088 |
| 1 | INDOCYANINE GREEN | 1 | 0.0083 |
| 2 | FLUORESCEIN SODIUM | 2 | 0.0065 |
| 3 | PEGCETACOPLAN | 11 | 0.0058 |
| 4 | AVACINCAPTAD PEGOL | 2 | 0.0057 |
| 5 | PROPARACAINE HYDROCHLORIDE | 2 | 0.0037 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 31 | 0.0037 |
| 7 | FOSCARNET SODIUM | 13 | 0.0032 |
| 8 | FLUORESCEIN | 2 | 0.0032 |
| 9 | TROPICAMIDE | 5 | 0.0031 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 133 |
| 1 | Corticosteroid [EPC] | 99 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 37 |
| 3 | Platinum-based Drug [EPC] | 35 |
| 4 | Glycopeptide Antibacterial [EPC] | 31 |
| 5 | Insulin Analog [EPC] | 31 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 31 |
| 7 | Proton Pump Inhibitor [EPC] | 29 |
| 8 | Nucleoside Analog Antiviral [EPC] | 26 |
| 9 | Azole Antifungal [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoenhancer [EPC] | 13 | 0.0033 |
| 1 | Diagnostic Dye [EPC] | 2 | 0.0031 |
| 2 | Antihypoglycemic Agent [EPC] | 9 | 0.0021 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | alpha-1 Adrenergic Agonist [EPC] | 6 | 0.0014 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 15 | 0.0012 |
| 6 | Antiseptic [EPC] | 5 | 0.0011 |
| 7 | Anticholinergic [EPC] | 15 | 0.0009 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 20 | 0.0009 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |